SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Intas Pharma Ltd. (Amalgamated) (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 NSE: | Pharmaceuticals & Drugs | Small Cap

Place order
BSE Share Price
Not Listed

Intas Pharma Ltd. (Amalgamated) (Amalgamated)

BSE: 0 NSE:
Pharmaceuticals & Drugs | Small Cap Place order
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Return on Capital Employed (ROCE)
5.68%
Current Price
₹0
Return on Equity (ROE)
-2.30%
Return on Assets (ROA)
-0.44%
Operating Profit Margin
20.4%
Net Profit Margin
-1.52%
Gross Profit Margin
12.9%
Book Value per Share
₹0
Sales Growth (YoY)
1416.52%
Sales Growth (3 Years)
NA%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
N/A%
Dividend Yield
0.00%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Intas Pharma(Amalgam

Based on:

M-Cap below 100cr DeciZen not available

Intas Pharma Ltd. (Amalgamated) (Amalgamated) stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

Mar'10Mar'11Mar'12TTM
ROCE % ⓘ0%-17.9%5.7%-

Growth Parameters ⓘ

Growth Parameters Colour Code Guide ⓘ

Sales ⓘ04.669.870
Sales YoY Gr.-NA1,416.5%-
Adj EPS ⓘ0-38.2-1.90
YoY Gr.-NANA-
BVPS (₹) ⓘ-8.127.243.50
Adj Net
Profit ⓘ		0-38.2-2.90
Cash Flow from Ops. ⓘ8.3-17.8-74.1-
Debt/CF from Ops. ⓘ15-6.9-2.2-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA1416.5%
Adj EPS ⓘNANANANA
BVPSⓘNANANA59.9%
Share Price - - - -

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

Mar'10Mar'11Mar'12TTM
Return on
Equity % ⓘ		0-182.1-6.30
Op. Profit
Mgn % ⓘ		0-402.320.4NAN
Net Profit
Mgn % ⓘ		0-829.9-4.10
Debt to
Equity ⓘ		-314.52.5-
Working Cap
Days ⓘ		01,6044470
Cash Conv.
Cycle ⓘ		01,0721770

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 69.8 -
BVPS (₹) ⓘ 0 -
Reserves (₹ Cr.) ⓘ 50 -
P/BV ⓘ 0.00 -
PE ⓘ 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE ⓘ 43.8

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Intas Pharma(Amalgam - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12
Sales04.6069.75
Operating Expenses ⓘ + 023.3955.55
Manufacturing Costs06.578.68
Material Costs08.6532.98
Employee Cost 04.195.87
Other Costs ⓘ 03.998.02
Operating Profit ⓘ 0-18.7914.20
Operating Profit Margin (%) --408.0%20.4%
Other Income ⓘ + 00.593.31
Exceptional Items ⓘ 000
Interest ⓘ 013.878.49
Depreciation ⓘ 05.906.80
Profit Before Tax ⓘ 0-37.972.22
Tax ⓘ 00.083.28
Profit After Tax 0-38.06-1.06
PAT Margin (%) --827.0%-1.5%
Adjusted EPS (₹)0.0-38.1-0.7
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12

Equity and Liabilities

Shareholders Fund + 14.7527.1965.23
Share Capital ⓘ 4.951015
Reserves ⓘ 9.8017.1950.23
Debt +124.53110.78148.55
Long Term Debt124.53110.78131.93
Short Term Debt0016.62
Minority Interest000
Trade Payables10.9134.3350.34
Others Liabilities ⓘ 1.3713.2428.85
Total Liabilities ⓘ 151.56185.55292.97

Fixed Assets

Net Fixed Assets ⓘ +0153.55153.64
Gross Block0159.39166.26
Accumulated Depreciation05.8412.62
CWIP ⓘ 124.1000
Investments ⓘ 000
Inventories4.1122.6257.25
Trade Receivables06.1974.47
Cash Equivalents 0.080.170.14
Others Assets ⓘ 23.273.027.47
Total Assets ⓘ 151.56185.55292.97

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12
Cash Flow From Operating Activity ⓘ + 8.28-17.82-74.05
PBT ⓘ 0-37.972.22
Adjustment ⓘ 020.0515.35
Changes in Working Capital ⓘ 8.130.1-91.62
Tax Paid ⓘ 0.1500
Cash Flow From Investing Activity ⓘ + -108.48-16.86-6.95
Capex -108.48-16.86-6.95
Net Investments 000
Others ⓘ 0-00
Cash Flow From Financing Activity ⓘ + 77.7134.5480.97
Net Proceeds from Shares ⓘ 050.5050
Net Proceeds from Borrowing ⓘ 77.7100
Interest Paid ⓘ 0-13.87-8.49
Dividend Paid ⓘ 000
Others ⓘ 0-2.1039.46
Net Cash Flow ⓘ -22.49-0.15-0.03

Finance Ratio

PARTICULARSMar'10Mar'11Mar'12
Ratios
ROE (%)0-328.42-2.3
ROCE (%)0-17.855.68
Asset Turnover Ratio00.030.29
PAT to CFO Conversion(x)N/AN/AN/A
Working Capital Days
Receivable Days0490.90211
Inventory Days01,060.40209
Payable Days0954.40468.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Intas Pharma Ltd. (Amalgamated) (Amalgamated) FAQs

The current trading price of Intas Pharma(Amalgam on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Intas Pharma(Amalgam stood at ₹0.00 Cr

The latest P/E ratio of Intas Pharma(Amalgam as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Intas Pharma(Amalgam as of 31-Dec-1969 is 0.00.

The 52-week high of Intas Pharma(Amalgam is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Intas Pharma(Amalgam is ₹69.75 ( Cr.) .

About Intas Pharma Ltd. (Amalgamated) (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×